| Literature DB >> 27031443 |
Fang Wang1, Linan Qiao1, Xing Lv2, Anna Trivett3, Rui Yang1, Joost J Oppenheim3, Ning Zhang4.
Abstract
Human neutrophil peptide 1 (HNP1), a predominant α defensin in the azurophilic granules of human neutrophils, is an alarmin capable of inducing the migration and maturation of human myeloid/conventional dendritic cells. However, it is not determined whether it can activate plasmacytoid dendritic cells (pDCs). Herein, we found that both human pDCs and CAL-1 cells, a pDC-like cell line, produced IFNα upon treatment with HNP1. Additionally, HNP1 could promote CpG ODN-induced pDC production of proinflammatory cytokines including IFNα. HNP1 triggered activation of NF-κB and nuclear translocation of interferon regulatory factor 1 (IRF1) in CAL-1 cells. HNP1 upregulation of cytokine expression in pDCs was inhibited by blockade of NF-κB activation or knockdown of IRF1, demonstrating the importance of these two signaling events in HNP1-induced pDC activation. Using a human pDC-nude mouse model, HNP1 was shown to induce IFNα production by human pDCs in vivo. Thus, HNP1 can activate human pDCs using NF-κB and IRF signaling pathways, and HNP-induced IFN production may participate in the inflammatory pathogenesis in certain authoimmune diseases such as rheumatoid arthritis.Entities:
Keywords: Alarmin; Defensin; HNP1; IFN; pDC
Mesh:
Substances:
Year: 2016 PMID: 27031443 PMCID: PMC7822553 DOI: 10.1016/j.cyto.2016.03.015
Source DB: PubMed Journal: Cytokine ISSN: 1043-4666 Impact factor: 3.861